STAT3 and hepatocellular carcinoma: Notably, LIF‐induced STAT3 signaling also participates in HCC development, exemplified by arsenic trioxide, which simultaneously suppresses the LIF/JAK1/STAT3 and NF‐kB signaling pathways, thereby promoting cancer stem cell differentiation and impeding HCC development [16].